Medicine & Health

Ana Maria Arbeláez, MD, and Stephanie A. Fritz, MD, have been named co-vice chairs of clinical investigation in the Department of Pediatrics at WashU Medicine.

A new study from WashU Medicine researchers describes the structure of an important protein that unspools the DNA molecule so the DNA can be repaired. Interfering with the protein could prove useful in developing new therapeutics for tuberculosis or other diseases caused by organisms that rely on these proteins to repair their DNA.

Two recent studies from researchers at WashU Medicine reveal that two vulnerable populations — children and recently pregnant women — face disparities in access to treatment for hepatitis C infection, putting them at risk of long-term health problems.

WashU Medicine researchers led by Siyuan Ding identified an immune-system protein in human cells that has the unusual capacity to respond to both DNA and RNA from pathogens, which may have implications for developing vaccines.

WashU Medicine faculty members received funding from the National Institutes of Health (NIH) to develop the Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases, a two-year mentored research experience.

The first sickle cell disease patient in the St. Louis region has been successfully treated by WashU Medicine physicians at St. Louis Children’s Hospital with a gene therapy newly approved by the Food and Drug Administration.

The National Institutes of Health (NIH) has awarded David M. Ornitz, MD, PhD, of WashU Medicine, $740,000 annually for four years to support research aimed at understanding respiratory complications associated with premature birth.

An interdisciplinary research team at Washington University in St. Louis has found that variability in sleep patterns in people experiencing pregnancy can effectively predict preterm birth.

Occupational therapy faculty member Kelly Harris, at WashU Medicine, will receive a $425,000 award to develop and test a technology-enabled care coordination service model to support Black youth with asthma.

The FDA has given market authorization to a WashU startup’s technology that quickly and accurately maps the sensitive areas in patients’ brains to help neurosurgeons plan safe and effective surgeries.